Pipeline
EM Imaging portfolio
Edinburgh Molecular Imaging has a portfolio of agents designed to improve detection and treatment of Cancer. All Agents progressed to date have been found to be safe, specific, sensitive and selective.
Therapy
*Indication to be disclosed at a later stage.
Imaging
EMI-137 (Optical Agent) was previously known as GE-137. See related publications here.